Newsfeeds - Spark Newswire

4 minute read

FDA
News

Teva Announces Its Launch Of Generic PERFOROMIST, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used To Treat Chronic Obstructive Pulmonary Disease (COPD), In The U.S.

Today, 9:59 AM

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its U.S. launch of the first generic version of twice daily PERFOROMIST®,formoterol fumarate

TEVA

1 minute read

Legal
News

Exelixis 8-K Shows. Co. Received Notice Letters From Teva Related To Abbreviated New Drug Application For CABOMETYX Tablets; Co. Filed Complaint In US For Patent Infringement Against Teva

By Benzinga Newsdesk

Today, 9:59 AM

In May 2021, Exelixis, Inc. (“Exelixis”) received notice letters from Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Development, Inc. (collectively, “Teva”) regarding an Abbreviated New

EXEL

4 minute read

Uncategorized

9 Health Care Stocks Showing Unusual Options Activity In Today’s Session

By Benzinga Insights

Today, 9:59 AM

This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Unusual trading activity could push option prices to hyperbolic or underperforming levels.

ABBV

1 minute read

Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $10

By Vick Meyer

Today, 9:59 AM

Wells Fargo maintains Teva Pharmaceutical Indus (NYSE:TEVA) with a Equal-Weight and raises the price target from $8 to…

TEVA

2 minute read

Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 202…

By Benzinga Newsdesk

Today, 9:59 AM

– Settlement with Teva represents final outstanding LINZESS patent litigation – – The earliest licensed entry of any…

AGN

Latest news

Teva Announces Its Launch Of Generic PERFOROMIST, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used To Treat Chronic Obstructive Pulmonary Disease (COPD), In The U.S.

Exelixis 8-K Shows. Co. Received Notice Letters From Teva Related To Abbreviated New Drug Application For CABOMETYX Tablets; Co. Filed Complaint In US For Patent Infringement Against Teva

9 Health Care Stocks Showing Unusual Options Activity In Today’s Session

Wells Fargo Maintains Equal-Weight on Teva Pharmaceutical Indus, Raises Price Target to $10

Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 202…